Sunlight is the Best Disinfectant: Real-Time Comment Letters and Large M&As in China
Journal of International Accounting Research · 01.03.2023 · 22 (1) · 137-168
DOI: 10.2308/jiar-2021-064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of International Accounting Research, online erschienen am 11.04.2023. Verfasst von Shuo Yang. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben.
Abstract (Originalsprache)
This paper investigates how communications between regulators and firms through comment letters affect the outcomes of large mergers and acquisitions (M&As) in China. Unlike the U.S. Securities and Exchange Commission (SEC), which uses comment letters to improve the accuracy of the measurement of deals, Chinese regulators worry about controlling shareholders' self-dealing and use real-time comment letters to expose suspicious deal specifics and to create pressure for controlling shareholders to back down. I find that the Chinese stock exchanges issue more severe comment letters on deal filings that indicate controlling shareholders’ expropriation of minority shareholders. More severe comment letters are associated with a lower market response to the receipt of letters, predict a higher probability of voluntary deal cancellation by management, and indirectly increase the probability of deal withdrawal and lengthen the processing time for equity-funded deals by affecting the approving body’s scrutiny level.
Zitieren
APA
Yang, S. (2023). Sunlight is the Best Disinfectant: Real-Time Comment Letters and Large M&As in China. Journal of International Accounting Research, 22(1), 137-168. https://doi.org/10.2308/jiar-2021-064
Vancouver
Yang S. Sunlight is the Best Disinfectant: Real-Time Comment Letters and Large M&As in China. Journal of International Accounting Research. 2023;22(1):137-168. doi:10.2308/jiar-2021-064
BibTeX
@article{Yang2023,
author = {Yang, Shuo},
title = {Sunlight is the Best Disinfectant: Real-Time Comment Letters and Large M&As in China},
journal = {Journal of International Accounting Research},
year = {2023},
volume = {22},
number = {1},
pages = {137--168},
doi = {10.2308/jiar-2021-064}
}
EUVIMED